NCT05476900View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Autoimmune Hepatitis.

PHASE2CompletedINTERVENTIONAL

Enrollment

69

Participants

Timeline

Start Date

October 6, 2022

Primary Completion Date

March 14, 2025

Study Completion Date

March 14, 2025

Conditions

Autoimmune Hepatitis

Interventions

DRUG

HR19042 Capsules

HR19042 Capsules

Trial Locations (1)

200120

Shanghai Jiao Tong University School of Medicine, Renji Hospital, Shanghai

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY